Regeneron Pharmaceuticals spent over *** billion U.S. dollars on research and development in 2024, up from *** billion U.S. dollars in the preceding year. The statistic illustrates the annual research and development expenses for Regeneron Pharmaceuticals between 2016 and 2024. Regeneron is a U.S-based global biotech company with headquarters in Tarrytown, New York.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Regeneron, & U.S. Securities and Exchange Commission. (February 5, 2025). Research and development expenses of Regeneron Pharmaceuticals from 2016 to 2024 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 22, 2026, from /statistics/1101981/regeneron-research-and-development-expenses/
Regeneron, und U.S. Securities and Exchange Commission. "Research and development expenses of Regeneron Pharmaceuticals from 2016 to 2024 (in million U.S. dollars)." Chart. February 5, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 22, 2026. /statistics/1101981/regeneron-research-and-development-expenses/
Regeneron, U.S. Securities and Exchange Commission. (2025). Research and development expenses of Regeneron Pharmaceuticals from 2016 to 2024 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 22, 2026. /statistics/1101981/regeneron-research-and-development-expenses/
Regeneron, and U.S. Securities and Exchange Commission. "Research and Development Expenses of Regeneron Pharmaceuticals from 2016 to 2024 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 5 Feb 2025, /statistics/1101981/regeneron-research-and-development-expenses/
Regeneron & U.S. Securities and Exchange Commission, Research and development expenses of Regeneron Pharmaceuticals from 2016 to 2024 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1101981/regeneron-research-and-development-expenses/ (last visited July 22, 2026)
Research and development expenses of Regeneron Pharmaceuticals from 2016 to 2024 (in million U.S. dollars) [Graph], Regeneron, & U.S. Securities and Exchange Commission, February 5, 2025. [Online]. Available: /statistics/1101981/regeneron-research-and-development-expenses/
